FP 802
Alternative Names: FP-802Latest Information Update: 05 Mar 2024
At a glance
- Originator FundaMental Pharma
- Class Neuroprotectants; Small molecules
- Mechanism of Action NMDA receptor antagonists; TRPM4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Amyotrophic lateral sclerosis